NGM·Healthcare·$172M·#361 / 520 in Healthcare

NNOX NANO-X IMAGING LTD

30HIGH RISK

CATEGORY BREAKDOWN

GROWTH22
QUALITY0
STABILITY61
VALUATION31
GOVERNANCE29

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

+13.9%
22

> 50% strong

Gross Margin

Revenue retained after direct costs

-94.0%
0

> 50% strong

Cash Runway

Months of cash at current burn rate

13 months
44

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

3.9%
97

< 25% strong

Price / Sales

Market cap relative to trailing revenue

14.0x
31

< 3x strong

Rule of 40

Growth rate plus operating margin

-489
0

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

0.2%
2

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

+2.5%
85

< 5% ideal

5 more metrics available

Unlock all 8 metrics, score history, watchlist, and side-by-side comparison.

Try Free for 30 Days

AI ANALYSIS REPORT

AI-GENERATED

BUSINESS SUMMARY

NANO-X IMAGING LTD (NNOX) is a healthcare company trading on NGM with a market capitalization of $172M. The company currently carries a HIGH RISK rating of 30/100, flagging significant fundamental concerns. The fundamental profile shows moderate revenue growth at 13.9% year-over-year, paired with negative gross margins, indicating the company sells below cost at -94.0%. The balance sheet shows minimal leverage with a very low debt-to-equity ratio, and the company has moderate cash runway of about 1 year.

VERDICT

NNOX scores 30/100 — the fundamentals flag multiple areas of concern. Only suitable for investors with high risk tolerance and a specific catalyst thesis. This report is based on the latest available financial data and is intended as a starting point for research, not a buy or sell recommendation.

MARKET OPPORTUNITY

In the healthcare sector, cash runway and pipeline progress are critical metrics. Revenue quality depends on whether income comes from product sales, partnerships, or milestones. NANO-X IMAGING LTD operates with low insider ownership of 0.2%, which may indicate limited management alignment, which provides a signal about management's confidence in the company's direction. At a market cap of $172M, the company is premium-valued, reflecting high growth expectations at 14.0x P/S. The combination of these factors positions NNOX as a higher-risk position that requires careful due diligence before considering an investment.

REVENUE QUALITY

Revenue growth stands at 13.9% year-over-year, which is in line with the typical small-cap growth rate. Gross margins of -94.0% are thin and may compress further under competitive pressure. The Rule of 40 score of -489 is well below the benchmark, indicating challenges in both growth and profitability. Cash runway of 13 months is adequate but should be monitored.

COMPETITIVE ADVANTAGE

Evaluating NANO-X IMAGING LTD's competitive position requires looking beyond the numbers. Insider ownership at 0.2% is relatively low, which may indicate that management's interests are less aligned with shareholders. The margin structure suggests the company operates in a competitive market where differentiation is harder to maintain. Share count management has been reasonable. Investors should research the specific sources of competitive advantage — patents, customer switching costs, scale economies, or brand — that could protect margins over time.

GROWTH THESIS

NNOX presents a speculative fundamental profile that requires a specific thesis to justify investment. Key catalysts to watch include: revenue growth trajectory over the next 2-3 quarters, margin expansion or contraction, and any changes in insider buying or selling activity.

KEY RISKS

Execution risk is significant — many small-cap companies in this sector fail to transition from growth to profitability. Limited cash runway of 13 months means the company may need to raise capital, potentially diluting existing shareholders. Thin gross margins leave little buffer against cost increases or competitive pricing pressure. Small-cap stocks carry inherently higher risk than large-caps, including limited analyst coverage, lower institutional ownership, and higher sensitivity to market downturns. Always conduct thorough due diligence beyond quantitative metrics.

Full AI Report available

Unlock the complete analysis including market opportunity, revenue quality, competitive moat, growth thesis, and risk assessment.

Try Free for 30 Days

Report generated: Mar 26, 2026

SCORE HISTORY

Track how this score changes over time. Start your free trial to see the full score trend chart.

SCORE ALERT

Get notified when NNOX's score changes by 5+ points.

DATA INFO

Last updated: Mar 11, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.